BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17208640)

  • 41. Expanded newborn screening by tandem mass spectrometry: the Massachusetts and New England experience.
    Marsden D
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():111-4. PubMed ID: 15906712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Newborn screening--is it really that simple?
    Wiley V; Carpenter K; Bayliss U; Wilcken B
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():107-10. PubMed ID: 15906711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the molecular spectrum of Medium-Chain Acyl-CoA Dehydrogenase Deficiency in a Greek newborns cohort: identification of a novel variant.
    Thodi G; Georgiou V; Molou E; Loukas YL; Dotsikas Y; Biti S; Papadopoulos K; Doulgerakis E
    Clin Biochem; 2012 Oct; 45(15):1167-72. PubMed ID: 22683754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retrospective study of the medium-chain acyl-CoA dehydrogenase deficiency in Portugal.
    Ventura FV; Leandro P; Luz A; Rivera IA; Silva MF; Ramos R; Rocha H; Lopes A; Fonseca H; Gaspar A; Diogo L; Martins E; Leão-Teles E; Vilarinho L; Tavares de Almeida I
    Clin Genet; 2014 Jun; 85(6):555-61. PubMed ID: 23829193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The clinical manifestation of MCAD deficiency: challenges towards adulthood in the screened population.
    Schatz UA; Ensenauer R
    J Inherit Metab Dis; 2010 Oct; 33(5):513-20. PubMed ID: 20532824
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A fatal neonatal presentation of medium-chain acyl coenzyme a dehydrogenase deficiency.
    Cyriac J; Venkatesh V; Gupta C
    J Int Med Res; 2008; 36(3):609-10. PubMed ID: 18534147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Deficiency of the fatty-acid oxidising enzyme medium-chain acyl-CoA dehydrogenase (MCAD) in an adult, detected during a neonatal screening programme].
    Derks TG; Jakobs H; Gerding A; Niezen-Koning KE; Reijngoud DJ; Smit GP
    Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2185-90. PubMed ID: 15559414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Newborn screening for medium chain acyl CoA dehydrogenase deficiency.
    Leonard JV; Dezateux C
    Arch Dis Child; 2009 Mar; 94(3):235-8. PubMed ID: 18838415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening for MCAD deficiency in newborns.
    Loughrey C; Bennett MJ
    BMJ; 2009 Mar; 338():b971. PubMed ID: 19282441
    [No Abstract]   [Full Text] [Related]  

  • 50. Homozygosity for a severe novel medium-chain acyl-CoA dehydrogenase (MCAD) mutation IVS3-1G > C that leads to introduction of a premature termination codon by complete missplicing of the MCAD mRNA and is associated with phenotypic diversity ranging from sudden neonatal death to asymptomatic status.
    Korman SH; Gutman A; Brooks R; Sinnathamby T; Gregersen N; Andresen BS
    Mol Genet Metab; 2004 Jun; 82(2):121-9. PubMed ID: 15171999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro correction of medium chain acyl CoA dehydrogenase deficiency with a recombinant adenoviral vector.
    Schowalter DB; Matern D; Vockley J
    Mol Genet Metab; 2005 Jun; 85(2):88-95. PubMed ID: 15896652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular diagnosis and characterization of medium-chain acyl-CoA dehydrogenase deficiency.
    Andresen BS; Bross P; Jensen TG; Knudsen I; Winter V; Kølvraa S; Bolund L; Gregersen N
    Scand J Clin Lab Invest Suppl; 1995; 220():9-25. PubMed ID: 7652482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunochemical characterization of variant medium-chain acyl-CoA dehydrogenase in fibroblasts from patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Coates PM; Indo Y; Young D; Hale DE; Tanaka K
    Pediatr Res; 1992 Jan; 31(1):34-8. PubMed ID: 1594327
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A neonatal death due to medium-chain acyl-CoA dehydrogenase deficiency: utilization of the neonatal metabolic screen in a functional approach to sudden unexplained infant death.
    Manoukian AA; Ha CE; Seaver LH; Bhagavan NV
    Am J Forensic Med Pathol; 2009 Sep; 30(3):284-6. PubMed ID: 19696588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of the prevalence of the 985A>G MCAD mutation in the French-Canadian population using allele-specific PCR.
    Giroux S; Dubé-Linteau A; Cardinal G; Labelle Y; Laflamme N; Giguère Y; Rousseau F
    Clin Genet; 2007 Jun; 71(6):569-75. PubMed ID: 17539907
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing the quality and value of metabolic chart data for capturing core outcomes for pediatric medium-chain acyl-CoA dehydrogenase (MCAD) deficiency.
    Iverson R; Taljaard M; Geraghty MT; Pugliese M; Tingley K; Coyle D; Kronick JB; Wilson K; Austin V; Brunel-Guitton C; Buhas D; Butcher NJ; Chan AKJ; Dyack S; Goobie S; Greenberg CR; Jain-Ghai S; Inbar-Feigenberg M; Karp N; Kozenko M; Langley E; Lines M; Little J; MacKenzie J; Maranda B; Mercimek-Andrews S; Mhanni A; Mitchell JJ; Nagy L; Offringa M; Pender A; Potter M; Prasad C; Ratko S; Salvarinova R; Schulze A; Siriwardena K; Sondheimer N; Sparkes R; Stockler-Ipsiroglu S; Tapscott K; Trakadis Y; Turner L; Van Karnebeek C; Vandersteen A; Walia JS; Wilson BJ; Yu AC; Potter BK; Chakraborty P
    BMC Pediatr; 2024 Jan; 24(1):37. PubMed ID: 38216926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis framework estimating prevalence of MCADD and sensitivity of newborn screening programme in the absence of direct evidence.
    Leal J; Wordsworth S; Oerton J; Khalid JM; Dezateux C;
    J Clin Epidemiol; 2014 Oct; 67(10):1131-8. PubMed ID: 24998633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcomes in pediatric studies of medium-chain acyl-coA dehydrogenase (MCAD) deficiency and phenylketonuria (PKU): a review.
    Pugliese M; Tingley K; Chow A; Pallone N; Smith M; Rahman A; Chakraborty P; Geraghty MT; Irwin J; Tessier L; Nicholls SG; Offringa M; Butcher NJ; Iverson R; Clifford TJ; Stockler S; Hutton B; Paik K; Tao J; Skidmore B; Coyle D; Duddy K; Dyack S; Greenberg CR; Ghai SJ; Karp N; Korngut L; Kronick J; MacKenzie A; MacKenzie J; Maranda B; Mitchell JJ; Potter M; Prasad C; Schulze A; Sparkes R; Taljaard M; Trakadis Y; Walia J; Potter BK;
    Orphanet J Rare Dis; 2020 Jan; 15(1):12. PubMed ID: 31937333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: evaluating the effects on outcome.
    Dezateux C
    Eur J Pediatr; 2003 Dec; 162 Suppl 1():S25-8. PubMed ID: 14628139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short-chain acyl-CoA dehydrogenase (SCAD) deficiency: an examination of the medical and neurodevelopmental characteristics of 14 cases identified through newborn screening or clinical symptoms.
    Waisbren SE; Levy HL; Noble M; Matern D; Gregersen N; Pasley K; Marsden D
    Mol Genet Metab; 2008; 95(1-2):39-45. PubMed ID: 18676165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.